Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Heinrich-Heine University, Duesseldorf
In order to answer the question, patients with breast cancer, who will undergo a chemotherapeutic treatment with antracycline, will be examined before chemotherapy (including cmr and echocardiography) and after chemotherapy at different times within one year.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Planned therapy with an anthracycline and at least 1 year follow up
\>18 years of age
written informed consent
You may not be if
prior cardiovascular disease
diabetes mellitus
previous therapy with anthracyclines
Clareo Health | Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping
